Abstract:Objective: To conduct research on Alzheimer's disease (AD) that is specifically focused on retinal functional and structural changes in TgAPPswePS1 transgenic mice; to demonstrate the role amyloid beta (Aβ) plays in retinal dysfunction; to provide new in sight into retinal AD pathology. Methods: APPswe/PS1 bigenic mice about 24 months of age (experimental group) and non-transgenic littermates about 24 months of age (control group) were grouped for experiments. The eyes of the TgAPPswePS1 mice were examined with electroretinography (ERG). The change in retinal morphology was investigated, while the expressions of the amyloid precursor protein (APP) and Aβ were examined with immunohistochemistry using retinal sections. All of the results were quantified and statistically analyzed by a student's t test. Results: In the experimental group, the rod response, which showed a reduction of the amplitudes of both a and b waves, was compared to the control group. The difference in the b wave amplitude was statistically significant (t=5.23, P=0.002). For maximum response amplitudes, both flash-triggered a waves and b waves showed a striking decrease compared to the control group. The difference in the a and b waves was statistically significant (t=15.69, 15.76, P<0.001). There were no significant structural abnormalities in the retinal sections in either the experimental or control groups. We found a decrease in the thickness of the retina in the experimental group compared to the controls, but the the difference was not statistically significant (t=1.85, P=0.087). In the experimental group, APP immunoreactivity was predominantly detected in the cytoplasm of cells in the ganglion cell layer as well as the inner nuclear layer. By comparison, a much lower staining intensity was observed in the control group in the corresponding regions of the retina. The Aβ accumulation in the retina could be detected by a diffuse pattern and plaque deposits. A majority of the Aβ-immunoreactive plaques were detected from the ganglion cell layer to the inner plexiform layer, the outer nuclear layer, and even in the photoreceptor outer segment layer. However, no Aβ positive immunoreactivity was detected in the retinas of mice in the control group. Conclusions: Aβ deposits accumulate in the retina of aged TgAPPswePS1 mice, which is associated with retinal degenerative changes in both function and structure. This suggests that AD-related pathology changes in the retina may contribute to the visual deficits seen in AD.

Amyloid-Peptide Vaccinations Reduce Beta-Amyloid Plaques but Exacerbate Vascular Deposition and Inflammation in the Retina of Alzheimer'S Transgenic Mice

The Accumulation of Aβ Deposits in the Retinas of APPswe/PS1 Transgenic Mice with Retinal Functional Degeneration

Amyloid Beta Deposition Related Retinal Pigment Epithelium Cell Impairment And Subretinal Microglia Activation In Aged Appsweps1 Transgenic Mice

Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease

Progress on Immunization with Amyloid-Beta in A Mouse Model of Alzheimer'S Disease

Amyloid-β (Aβ) immunotherapy induced microhemorrhages are linked to vascular inflammation and cerebrovascular damage in a mouse model of Alzheimer's disease

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes

Vaccines targeting the primary amino acid sequence and conformational epitope of amyloid- had distinct effects on neuropathology and cognitive deficits in EAE/AD mice

Amyloid-Beta Immunotherapy for the Prevention and Treatment of Alzheimer Disease: Lessons from Mice, Monkeys, and Humans

Vaccines targeting the primary amino acid sequence and conformational epitope of Aβ had distinct effects on neuropathology and cognitive deficits in EAE/AD mice.

Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-Beta Peptide, Partial Restoration Via Gamma-Secretase Inhibition

Amyloid-β (Aβ) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer's disease mice

Changes of Amyloid Β-Protein Level and Astrocytes in the Retina of APP/PS1 Double Transgenic Mouse Models

Vaccines targeting the primary amino acid sequence and conformational epitope of amyloid‐β had distinct effects on neuropathology and cognitive deficits in EAE/AD mice

Amyloid Beta Pathology Accelerates Alterations in the Visual Pathway of the 5xFAD Mouse

Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer's Disease

Tau, synapse loss and gliosis progress in an Alzheimer's mouse model after amyloid-β immunotherapy

Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer's disease